NCT06166303

Brief Summary

Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit. Although the usefulness of angiogenic factors in these scenarios is known, little is known about the effects that other conditions might have on their serum levels, mainly those that have an effect on trophoblastic invasion, the process that initiates implantation of the pregnancy in the endometrium. The purpose of the present study is to assess the effect that a history of uterine surgery, such as caesarean section, might have on angiogenic factor scores in subjects with no history of a hypertensive disorder of pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
540

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
1.8 years until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

December 4, 2023

Last Update Submit

August 23, 2025

Conditions

Keywords

Cesarean sectionAngiogenic factorsPreeclampsia

Outcome Measures

Primary Outcomes (1)

  • Index sFlt-1/PIGF

    Angiogenic factors, normal value.

    From the moment of randomization up until delivery. Between 24-48 hours.

Secondary Outcomes (1)

  • Progression to preeclampsia

    Up until discharge. On average, 7 days

Study Arms (2)

Previous Cesarean Section

Subjects with one or more previous cesarean sections

Diagnostic Test: sFlt-1/PGIF

No Cesarean

Subjects scheduled for an elective or urgent cesarean, but no history of previous cesarean section

Diagnostic Test: sFlt-1/PGIF

Interventions

sFlt-1/PGIFDIAGNOSTIC_TEST

Index of sFlt-1/PGIF

No CesareanPrevious Cesarean Section

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Pregnant woman with a previous cesarean section

You may qualify if:

  • weeks of gestation or more
  • Singleton pregnancy
  • Previous cesarean section (case)

You may not qualify if:

  • Vasculitis
  • Twin pregnancy
  • Chronic endometritis
  • Smoking
  • Lupus
  • Renal failure
  • Liver disease
  • Thrombocytopenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Thomas H

Panama City, Provincia de Panamá, Panama

Location

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Osvaldo Reyes

    Hospital Santo Tomás

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Osvaldo Reyes, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the research deparment

Study Record Dates

First Submitted

December 4, 2023

First Posted

December 12, 2023

Study Start

October 1, 2025

Primary Completion

January 30, 2026

Study Completion

March 30, 2026

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations